a female researcher looking at cells on a slide

Alvin H. Schmaier, of the Department of Pathology, explains how certain anticoagulants could aid patients at risk of developing thrombosis

Anticoagulation Is Key for Adjunctive Therapy in Thrombosis Management

OncLive: Alvin H. Schmaier, a professor in the Department of Medicine and the Department of Pathology, discussed the primary and secondary management of cancer-related thrombosis, explaining that patients at risk of developing thrombosis should receive certain anticoagulants to control excessive bleeding: “When you give an anticoagulant in the current era, it’s a balance between preventing clots, but not giving [too much] anticoagulation in that patients hemorrhage. That’s the major complication,” said Schmaier. “To address that, we now have antidotes to [specific] inhibitors.”